share_log

Cracking The Code: Understanding Analyst Reviews For QuidelOrtho

Cracking The Code: Understanding Analyst Reviews For QuidelOrtho

破解密码:理解窥得儿医药的分析师评论
Benzinga ·  09/19 17:01
Ratings for QuidelOrtho (NASDAQ:QDEL) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去的三个月中,窥得儿医药(纳斯达克:QDEL)的评级由4位分析师提供,展示了看好和看淡的观点混合在一起。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估,下表展示了过去30天内不断变化的情绪,并将其与之前的几个月进行了比较。
Analysts have set 12-month price targets for QuidelOrtho, revealing an average target of $57.25, a high estimate of $61.00, and a low estimate of $50.00. Surpassing the previous average price target of $51.00, the current average has increased by 12.25%.
分析师们为窥得儿医药设定了为期12个月的价格目标,显示出平均目标为57.25美元,最高估值为61.00美元,最低估值为50.00美元。超过了之前的平均目标价51.00美元,当前的平均值增加了12.25%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级:详细剖析
The standing of QuidelOrtho among financial experts becomes clear with a thorough analysis of recent...
通过对最近分析师行动的全面分析...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发